Evidence map›Paper›PMID 22072939›Full record

ReviewInternational journal of molecular sciences2011

Manganese superoxide dismutase: guardian of the powerhouse.

Aaron K Holley, Vasudevan Bakthavatchalu, Joyce M Velez-Roman, Daret K St Clair

Open access · goldAbstract readReview
In one paragraph

Review in International journal of molecular sciences, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 182 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
182citing papers in PubMed, 1 pooled it
6.5field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

182 citing papers in PubMed, 1 synthesis or guideline pooled it, 343 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. MnAntioxidants (Basel, Switzerland) · 2026
    Article
  14. Review
  15. Article
  16. Review
  17. Timing and method of manganese supplementation effects thermal resilience of Acropora millepora.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2026
    Article
  18. Review
  19. Article
  20. Article

122 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Aaron K HolleyGraduate Center for Toxicology, University of Kentucky, 454 HSRB, 1095 VA Drive, Lexington, KY 40536, USA; E-Mails: aaron.holley@uky.edu (A.K.H.); vbakt2@uky.edu (V.B.); joycemarievr@hotmail.com (J.M.V.-R.).
Vasudevan Bakthavatchalu
Joyce M Velez-Roman
Daret K St Clair
The Graduate Center, CUNY · USUniversity of Kentucky · US

Funding

REDOX REGULATION OF TUMOR SUPPRESSION BY MNSODR01CA073599 · NCI · UNIVERSITY OF KENTUCKY · PI ST CLAIR, DARET K · 1998 to 2012
$4.0M
TRAINING GRANT IN MOLECULAR MECHANISMS OF TOXICITY.T32ES007266 · NIEHS · UNIVERSITY OF KENTUCKY · PI LIU, XIAOQI, MELLON, ISABEL W · 1990 to 2020
$3.7M
NCI NIH HHS 3R01CA73599-05S1NCI NIH HHS 5R01CA073599-11NCI NIH HHS R01 CA073599NIEHS NIH HHS 2T32ES007266-21NIEHS NIH HHS T32 ES007266
6 · The paper itself

Abstract

The mitochondrion is vital for many metabolic pathways in the cell, contributing all or important constituent enzymes for diverse functions such as β-oxidation of fatty acids, the urea cycle, the citric acid cycle, and ATP synthesis. The mitochondrion is also a major site of reactive oxygen species (ROS) production in the cell. Aberrant production of mitochondrial ROS can have dramatic effects on cellular function, in part, due to oxidative modification of key metabolic proteins localized in the mitochondrion. The cell is equipped with myriad antioxidant enzyme systems to combat deleterious ROS production in mitochondria, with the mitochondrial antioxidant enzyme manganese superoxide dismutase (MnSOD) acting as the chief ROS scavenging enzyme in the cell. Factors that affect the expression and/or the activity of MnSOD, resulting in diminished antioxidant capacity of the cell, can have extraordinary consequences on the overall health of the cell by altering mitochondrial metabolic function, leading to the development and progression of numerous diseases. A better understanding of the mechanisms by which MnSOD protects cells from the harmful effects of overproduction of ROS, in particular, the effects of ROS on mitochondrial metabolic enzymes, may contribute to the development of novel treatments for various diseases in which ROS are an important component.

Indexed as

AnimalsCardiovascular DiseasesElectron Transport Chain Complex ProteinsHumansImmunity, InnateMetabolic DiseasesMitochondriaNeoplasmsNervous System DiseasesOxidative StressReactive Oxygen SpeciesSuperoxide DismutaseSuperoxide Dismutase 2Electron Transport Chain Complex ProteinsReactive Oxygen SpeciesSuperoxide DismutaseSuperoxide Dismutase 2cancercardiovascular diseasemanganese superoxide dismutasemetabolismmitochondrianeurodegenerative disordersoxidative stressreactive oxygen species

Identifiers

PMID22072939
PMCPMC3211030
OpenAlexW2014175688

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.